December 11, 2024 - 02:58

In a recent press conference, head coach Kyle Shanahan and defensive coordinator Nick Sorensen provided crucial updates regarding player injuries and the team's strategy as they gear up for their upcoming game against the Rams. They specifically addressed the status of running back Isaac Gurendo and defensive lineman Nick Bosa, both of whom have been dealing with injuries.
Shanahan emphasized the importance of taking care of business as the team faces a short turnaround this week. He acknowledged the challenges that come with preparing for a game in such a limited timeframe but expressed confidence in the team's ability to adapt and perform. Sorensen echoed these sentiments, highlighting the need for the players to stay focused and execute their game plan effectively.
As the team navigates the complexities of injuries and a tight schedule, both coaches remain optimistic about their players' resilience and readiness to compete against a formidable Rams squad. The emphasis on preparation and teamwork will be crucial as they aim for a successful outcome in the upcoming matchup.
June 27, 2026 - 07:59
Gilbert Chamber Foundation brings AI basics to local businessesBusiness owners in Gilbert and the East Valley are getting a hands-on look at how artificial intelligence could keep them competitive. The Gilbert Chamber Foundation has introduced a new initiative...
June 26, 2026 - 18:02
Meet ‘Pepper’ Baumer, The Man With Hot Sauce In His BloodHot sauce has become one of the fastest-growing sectors in the food industry, and few people understand that heat better than `Pepper` Baumer. As the third-generation owner of Crystal, a...
June 26, 2026 - 11:50
‘Disgusting and vile’: Locals react to arrest of Tampa business owner on AI child porn chargesA Tampa business owner is behind bars this week, facing more than 100 felony charges after authorities say he used artificial intelligence to create child pornography. Local residents and fellow...
June 25, 2026 - 20:17
Investigational heart drug for nonobstructive HCM one step closer to FDA approvalAn experimental oral medication for a specific type of hypertrophic cardiomyopathy is advancing toward potential U.S. approval. The drug, known as ninerafaxstat, is being developed for patients...